Insmed (INSM) EBT Margin (2010 - 2026)

Insmed (INSM) posted quarterly EBT Margin of 52.98% for Q1 2026, up 22246.0% year-over-year from N/an in Q1 2025, and up 57.24% quarter-over-quarter from 123.91% in Q4 2025.

Insmed (INSM) EBT Margin (2010 - 2026) Analysis & Trends

Insmed's EBT Margin history runs 12 years deep, the most recent figure standing at 52.98% for Q1 2026.

  • In Q1 2026, EBT Margin rose 22246.0% year-over-year to 52.98%; the TTM figure through Mar 2026 stood at 143.76% (up 12111.0% YoY), while the FY2025 annual figure was 209.71%, up 4051.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 52.98%, up from 123.91% in the prior quarter.
  • The five-year high for EBT Margin was 52.98% in Q1 2026, with the low at 331.83% in Q2 2024.
  • The 5-year median for EBT Margin is 224.32% (2024), against an average of 222.13%.
  • The sharpest annual moves came in 2023 and 2026: EBT Margin plunged 17043 bps in 2023, then soared 22246 bps in 2026.
  • Insmed's EBT Margin stood at 269.81% in 2022, then climbed by 18 bps to 221.12% in 2023, then declined by 1 bps to 224.32% in 2024, then soared by 45 bps to 123.91% in 2025, then surged by 57 bps to 52.98% in 2026.
  • Business Quant data shows INSM's EBT Margin at 52.98% in Q1 2026, 123.91% in Q4 2025, and 259.02% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 35.61%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 34.77%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 18.33%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -94.22%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 13.77%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -2.67%
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn -20,427.46%

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.67%
Mar 31, 2026 -52.98%
Dec 31, 2025 -123.91%
Sep 30, 2025 -259.02%
Jun 30, 2025 -298.32%
Mar 31, 2025 -275.44%
Dec 31, 2024 -224.32%
Sep 30, 2024 -234.96%
Jun 30, 2024 -331.83%
Mar 31, 2024 -207.29%
Dec 31, 2023 -221.12%
Sep 30, 2023 -200.31%
Jun 30, 2023 -316.30%
Mar 31, 2023 -244.24%
Dec 31, 2022 -269.81%
Sep 30, 2022 -193.08%
Jun 30, 2022 -145.88%
Mar 31, 2022 -177.45%
Dec 31, 2021 -201.37%
Sep 30, 2021 -246.58%